Prediction of Activity of Carbonic Anhydrase Inhibitor Drugs Based on QSAR Studies

被引:2
|
作者
Darzi, N. [1 ]
Morsali, A. [1 ]
Beyramabadi, S. A. [1 ]
机构
[1] Islamic Azad Univ, Mashhad Branch, Dept Chem, Mashhad, Iran
关键词
Binding constant; DFT; QSAR; Sulphonamides;
D O I
10.13005/ojc/310264
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A quantitative structure-activity relationship (QSAR) model, based on three quantum chemical descriptors obtained from the benzene sulphonamide derivatives using the density functional theory (DFT) method. Then this developed model was used to predict the benzene sulphonamide binding constant. The QSAR model has correlation coefficient R of 0.901 and the standard error of 0.646. Also, the predictive power of this model was further examined by leave-7-out cross validation procedure which the obtained statistical parameters were: Q(2)=0.991 and SPRESS=0.4686 that giving a good enough predictive power. The selected descriptorsare: molecular weight (MW), absolute hardness (AH), HOMO energy (HOMO), respectively.
引用
收藏
页码:1121 / 1125
页数:5
相关论文
共 50 条
  • [31] QSAR studies on carbonic anhydrase inhibitors: A case of ureido and thioureido derivatives of aromatic/heterocyclic sulfonamides
    Agrawal, VK
    Sharma, R
    Khadikar, PV
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (09) : 2993 - 2999
  • [32] Some QSAR studies for a group of sulfonamide Schiff base as carbonic anhydrase CA II inhibitors
    Eroglu, Erol
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2008, 9 (02) : 181 - 197
  • [33] Enzymatic activity of carbonic anhydrase
    Kreps, EM
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES DE L URSS, 1944, 45 : 197 - 198
  • [34] DETERMINATION OF CARBONIC ANHYDRASE ACTIVITY
    CLARK, AM
    NATURE, 1949, 163 (4145) : 562 - 563
  • [35] Bioinspired Imprinted PHEMA-Hydrogels for Ocular Delivery of Carbonic Anhydrase Inhibitor Drugs
    Ribeiro, Andreza
    Veiga, Francisco
    Santos, Delfim
    Torres-Labandeira, Juan J.
    Concheiro, Angel
    Alvarez-Lorenzo, Carmen
    BIOMACROMOLECULES, 2011, 12 (03) : 701 - 709
  • [36] Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies
    Aspatwar, Ashok
    Winum, Jean-Yves
    Carta, Fabrizio
    Supuran, Claudiu T.
    Hammaren, Milka
    Parikka, Mataleena
    Parkkila, Seppo
    MOLECULES, 2018, 23 (11):
  • [37] Synthesis, spectroscopic characterizations, carbonic anhydrase II inhibitory activity, anticancer activity and docking studies of new Schiffbases of sulfa drugs
    Alyar, Saliha
    Ozmen, Ummuhan Ozdemir
    Adem, Sevki
    Alyar, Hamit
    Bilen, Esra
    Kaya, Kerem
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1223
  • [38] Extracellular carbonic anhydrase activity and carbonic anhydrase inhibitors in the circulatory system of fish
    Henry, RP
    Gilmour, KM
    Wood, CM
    Perry, SF
    PHYSIOLOGICAL ZOOLOGY, 1997, 70 (06): : 650 - 659
  • [39] Purification, enzymatic activity and inhibitor discovery for recombinant human carbonic anhydrase XIV
    Matulis, Daumantas
    Juozapaitiene, Vaida
    Bartkute, Brigita
    Michailovien, Vilma
    Zaksauskas, Audrius
    Baranauskien, Lina
    Satk, Sandra
    JOURNAL OF BIOTECHNOLOGY, 2016, 231 : S10 - S10
  • [40] Interaction Studies between Carbonic Anhydrase and a Sulfonamide Inhibitor by Experimental and Theoretical Approaches
    Pagnozzi, Daniela
    Pala, Nicolino
    Biosa, Grazia
    Dallocchio, Roberto
    Dessi, Alessandro
    Singh, Pankaj Kumar
    Rogolino, Dominga
    Di Fiore, Anna
    De Simone, Giuseppina
    Supuran, Claudiu T.
    Sechi, Mario
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (02): : 271 - 277